Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

59.12 +0.72 (+1.23%)
Official Closing Price Updated: 4:10 PM EDT, Sep 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Stock Market Today: Hims & Hers Tumbles 12% on Revenue Miss Despite 73% Growth
Hims & Hers stock fell sharply Tuesday after the company missed Q2 revenue estimates, despite strong growth and reaffirmed guidance. 
Via The Motley Fool
HIMS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
From The Rosen Law Firm PA
Via GlobeNewswire
Earnings Season Wrap-Up: Tech Giants Shine, Others Face Mixed Results
The latest earnings season, spanning late July and early August 2025, has painted a vivid picture of a bifurcated market, where the titans of technology continue to defy gravity, largely propelled by... 
Via MarketMinute
Topics Artificial Intelligence Economy
Hims & Hers Tumbles After-Hours On Q2 Miss, GLP-1 Slowdown — But Retail Traders Eye Bargain Entry
Via Stocktwits
US Market Under Pressure: Amazon, Eastman Chemical, and Hims & Hers Among Top Losers
The U.S. stock market experienced a turbulent start to August 2025, marked by significant declines for several prominent companies. This downturn, following a volatile end to July, has left investors... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Palantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Today
Via Stocktwits
Hims & Hers Stock Is Trading Lower Tuesday: What's Going On?
 
Via Benzinga
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
Stocks Drop As Trump Tariffs Fuel Inflation, Palantir Hits $400 Billion Value: What's Moving Market Tuesday?
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc. 
Via Benzinga
Topics Economy Government
Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say
Hims & Hers Health (HIMS) stock falls after reporting lower Q2 revenues. Analysts caution about near-term challenges, including regulatory complexity. 
Via Benzinga
Why Hims & Hers Health Stock Just Dropped
Hims & Hers stock just got cheaper -- and it's still too expensive to buy. 
Via The Motley Fool
Why Did Hims & Hers Stock Crash and Then Recover After Earnings?
HIMS stock was down 13% after the company reported earnings. 
Via The Motley Fool
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
From Pomerantz LLP
Via GlobeNewswire
3 Stocks to Hold for 20 Years
These stocks have decades of compounding growth ahead. 
Via The Motley Fool
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Lost Money on Hims &amp; Hers Health, Inc. (HIMS)? Join Class Action Suit Seeking Recovery - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Deep Dive Into Hims & Hers Health Stock: Analyst Perspectives (3 Ratings)
 
Via Benzinga
Novo Nordisk Stock Sinks—But Is a Bottom Finally In?
Novo Nordisk stock is down over 43% in 2025 as investors weigh weak guidance, GLP-1 competition, and the potential for a rebound after earnings 
Via MarketBeat
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: What's Going On?
Hims & Hers Health Inc. (NYSE: HIMS) plunged 13.1% in Tuesday pre-market after the digital health company reported second-quarter revenue on Monday that missed Wall Street expectations. 
Via Benzinga
Palantir, Hims & Hers, American Eagle, Joby Aviation And AMD: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices ended Monday in the green with the Dow Jones Industrial Average rising 1.3% higher at 44,173.64. 
Via Benzinga
Topics Stocks
Hims & Hers (HIMS) Q2 Revenue Jumps 73%
Via The Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Which stocks are moving after the closing bell on Monday?
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Hims & Hers Health (NYSE:HIMS) Misses Q2 Revenue Estimates, Stock Drops 12%
Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 72.6% year on year to $544.8 million. On the other hand, the company... 
Via StockStory
Hims & Hers Health Stock Tumbles On Q2 Earnings As Revenue Comes Up Short, Company Sees 'Exciting Period Of Growth' Ahead
Hims & Hers Health reports second-quarter revenue of $544.83 million, missing analyst estimates of $549.83 million. 
Via Benzinga
IBD 50's Hims & Hers Plummets 9% On Second-Quarter Sales Miss
The company reiterated its sales outlook for the year, despite coming in with lighter-than-expected second-quarter sales. 
Via Investor's Business Daily
Topics ETFs Earnings
Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results
From Hims & Hers
Via Business Wire
Class Action Reminder for HIMS Investors: Kessler Topaz Meltzer &amp; Check, LLP Reminds Hims &amp; Hers Health, Inc. (HIMS) Investors of Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
Class Action Reminder for HIMS Investors: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Securities Fraud Class Action Lawsuit
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.